Zura Bio(ZURA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ZURA Zura Bio

Market Closed 04-11 16:00:00 EDT

1.21

+0.09

+8.04%

盘后1.25

+0.04+3.31%

19:45 EDT

High1.22	Low1.09	Vol181.70K
Open1.13	D1 Closing1.12	Amplitude11.60%
Mkt Cap82.73M	Tradable Cap56.41M	Total Shares68.37M
T/O213.02K	T/O Rate0.39%	Tradable Shares46.62M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"ZURA","market":"US","secType":"STK","nameCN":"Zura Bio","latestPrice":1.21,"timestamp":1744401600000,"preClose":1.12,"halted":0,"volume":181702,"hourTrading":{"tag":"盘后","latestPrice":1.25,"preClose":1.21,"latestTime":"19:45 EDT","volume":273,"amount":340.404,"timestamp":1744415156567},"delay":0,"floatShares":46618183,"shares":68374998,"eps":-0.604576,"marketStatus":"Market Closed","change":0.09,"latestTime":"04-11 16:00:00 EDT","open":1.13,"high":1.22,"low":1.0901,"amount":213016.55902040002,"amplitude":0.115982,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.604576,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1744617600000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":1.12,"preHourTrading":{"tag":"盘前","latestPrice":1.0647,"preClose":1.12,"latestTime":"09:24 EDT","volume":1400,"amount":1490.58,"timestamp":1744377850753},"postHourTrading":{"tag":"盘后","latestPrice":1.25,"preClose":1.21,"latestTime":"19:45 EDT","volume":273,"amount":340.404,"timestamp":1744415156567},"volumeRatio":0.28884354476774454,"impliedVol":0.7265,"impliedVolPercentile":0.2892},"requestUrl":"/m/hq/s/ZURA","defaultTab":"news","newsList":[{"id":"2524230141","title":"Zura Bio Is Maintained at Neutral by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2524230141","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524230141?lang=en_us&edition=full_marsco","pubTime":"2025-04-03 19:12","pubTimestamp":1743678720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ZURA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 03, 2025 07:12 ET (11:12 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZURA"],"gpt_icon":0},{"id":"2524234953","title":"Zura Bio price target lowered to $3 from $5 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2524234953","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524234953?lang=en_us&edition=full_marsco","pubTime":"2025-04-03 18:16","pubTimestamp":1743675367,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Mitchell Kapoor lowered the firm’s price target on Zura Bio (ZURA) to $3 from $5 and keeps a Buy rating on the shares follo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/zura-bio-price-target-lowered-to-3-from-5-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/zura-bio-price-target-lowered-to-3-from-5-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ZURA"],"gpt_icon":0},{"id":"2523605490","title":"Zura Bio (ZURA) Gets a Buy from Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2523605490","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523605490?lang=en_us&edition=full_marsco","pubTime":"2025-03-30 21:45","pubTimestamp":1743342312,"startTime":"0","endTime":"0","summary":"In a report released on March 26, Yatin Suneja from Guggenheim reiterated a Buy rating on Zura Bio (ZURA – Research Report), with a price target of...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/zura-bio-zura-gets-a-buy-from-guggenheim?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/zura-bio-zura-gets-a-buy-from-guggenheim?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"2522792733","title":"Zura Bio Ltd reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2522792733","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522792733?lang=en_us&edition=full_marsco","pubTime":"2025-03-27 19:31","pubTimestamp":1743075064,"startTime":"0","endTime":"0","summary":"Zura Bio Ltd reports results for the quarter ended December 31 - Earnings SummaryZura Bio Ltd ZURA.OQ reported a quarterly adjusted loss of 10 cents per share for the quarter ended December 31, higher","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nL5N3QA0X8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZURA"],"gpt_icon":0},{"id":"2522384396","title":"Hopeful Week For Insiders Who Bought US$1.01m Of Zura Bio Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2522384396","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522384396?lang=en_us&edition=full_marsco","pubTime":"2025-03-26 23:16","pubTimestamp":1743002219,"startTime":"0","endTime":"0","summary":"Insiders who bought US$1.01m worth of Zura Bio Limited  stock in the last year have seen some of their losses recouped as the stock gained 12% last week. However, total losses seen by insiders are still US$644k since the time of purchase.While insider transactions are not the most important thing when it comes to long-term investing, we do think it is perfectly logical to keep tabs on what insiders are doing.We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.The Last 12 Months Of Insider Transactions At Zura Bio. It doesn't really mean much that no insider has traded Zura Bio shares in the last quarter. On a brighter note, the transactions over the last year are encouraging. The transactions are fine but it'd be more encouraging if Zura Bio insiders bought more shares in the company. So while it's helpful to know what in","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/hopeful-week-insiders-bought-us-151659091.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ZURA","BK4139","ZURAW"],"gpt_icon":0},{"id":"2522727318","title":"Zura Bio Is Maintained at Buy by Chardan Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2522727318","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522727318?lang=en_us&edition=full_marsco","pubTime":"2025-03-26 20:13","pubTimestamp":1742991180,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ZURA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 26, 2025 08:13 ET (12:13 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZURA"],"gpt_icon":0},{"id":"2522872397","title":"Zura Bio Limited : Oppenheimer Cuts Target Price to $19 From $20","url":"https://stock-news.laohu8.com/highlight/detail?id=2522872397","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522872397?lang=en_us&edition=full_marsco","pubTime":"2025-03-26 20:11","pubTimestamp":1742991106,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nAZN3MCDXB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"2522714118","title":"Chardan Cuts Price Target on Zura Bio to $10 From $12, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2522714118","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522714118?lang=en_us&edition=full_marsco","pubTime":"2025-03-26 19:55","pubTimestamp":1742990151,"startTime":"0","endTime":"0","summary":"Zura Bio (ZURA) has an average rating of buy and mean price target of $15.40, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ZURA"],"gpt_icon":0},{"id":"2522304787","title":"Zura Bio FY2024 GAAP EPS Of $(0.60) Vs. $(2.09) YoY, Cash And Cash Equivalents Were $176.5M As Of December 31, 2024, Expected To Provide Cash Runway Through 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2522304787","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522304787?lang=en_us&edition=full_marsco","pubTime":"2025-03-25 18:43","pubTimestamp":1742899421,"startTime":"0","endTime":"0","summary":"Zura Bio FY2024 GAAP EPS Of $(0.60) Vs. $(2.09) YoY, Cash And Cash Equivalents Were $176.5M As Of December 31, 2024, Expected To Provide Cash Runway Through 2027","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/general/biotech/25/03/44470212/zura-bio-fy2024-gaap-eps-of-0-60-vs-2-09-yoy-cash-and-cash-equivalents-were-176-5m-as-of-december","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZURA"],"gpt_icon":0},{"id":"2522904428","title":"Zura Bio Ltd  expected to post a loss of 16 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2522904428","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522904428?lang=en_us&edition=full_marsco","pubTime":"2025-03-25 18:32","pubTimestamp":1742898777,"startTime":"0","endTime":"0","summary":"Zura Bio Ltd  expected to post a loss of16cents a share - Earnings Preview Zura Bio Ltd ZURA.OQ ZURA.O is expected to show no change in quarterly revenue when it reports  results on March 27 (estimate","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nL5N3Q80LR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZURA"],"gpt_icon":0},{"id":"2522044239","title":"Zura Bio Ltd - Cash Runway Anticipated Through 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2522044239","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522044239?lang=en_us&edition=full_marsco","pubTime":"2025-03-25 18:30","pubTimestamp":1742898600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nTUA1PJCXH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"2522023540","title":"Zura Bio Reports Full Year 2024 Financial Results and Recent Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2522023540","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522023540?lang=en_us&edition=full_marsco","pubTime":"2025-03-25 18:30","pubTimestamp":1742898600,"startTime":"0","endTime":"0","summary":"Achieved key milestones in 2024 that enhanced our leadership team, strengthened our financial position, and progressed our clinical pipeline. Initiated the Phase 2 TibuSURE trial in adults with systemic sclerosis . Completed a $112.5 million private placement financing in April 2024, contributing to a total of $176.5 million in cash and cash equivalents, as of December 31, 2024. Cash runway anticipated through 2027, supporting operations and funding anticipated tibulizumab data readouts in SSc and hidradenitis suppurativa . HENDERSON, Nev., March 25, 2025----Zura Bio Limited  , a clinical stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases, today reported full year 2024 financial results and recent corporate updates.\"In 2024, we reached key milestones that reinforced our financial foundation, expanded our leadership team, and advanced our clinical pipeline, highlighting our commitment to establishing a leading presence","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zura-bio-reports-full-2024-103000915.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","ZURAW","ZURA"],"gpt_icon":0},{"id":"2521714099","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2521714099","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521714099?lang=en_us&edition=full_marsco","pubTime":"2025-03-24 18:00","pubTimestamp":1742810400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Comp de San Bas                                  4Q       .36       AMC. ·Oklo Inc. Class A                               4Q      (.07)      AMC. ·Core & Main Inc.                                 4Q       .36       BMO. ·McCormick & Co                                 1Q       .64   6:30 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALUR","LPTX","MREO","UNCY","GRDN","IKT","PAYS","PAYX","ZURA","PDSB","EDAP","WGO","CALC","MKC","ANTX","OBIO","DLTR","BEEM","WOOF","MDAI","MLKN","KBH","CDLR","SDST","NUTX","SLRN","WBA","CNXC","BCAB","KOD","RLMD","XFOR","CRMD","DERM","CHWY","IOBT","SURG","GOVX","CTAS","THRD","CLSD","ACRV","SKYX","AFMD","ABL","FBIO","IVA","RVPH","SCS","TEN"],"gpt_icon":0},{"id":"2517205178","title":"Zura Bio’s Growth Potential: Buy Rating Backed by Key Catalysts and Phase 2 Developments","url":"https://stock-news.laohu8.com/highlight/detail?id=2517205178","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517205178?lang=en_us&edition=full_marsco","pubTime":"2025-03-07 14:55","pubTimestamp":1741330554,"startTime":"0","endTime":"0","summary":"Faisal Khurshid, an analyst from Leerink Partners, reiterated the Buy rating on Zura Bio (ZURA – Research Report). The associated price target is $...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/zura-bios-growth-potential-buy-rating-backed-by-key-catalysts-and-phase-2-developments?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/zura-bios-growth-potential-buy-rating-backed-by-key-catalysts-and-phase-2-developments?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ZURA"],"gpt_icon":0},{"id":"2513723390","title":"Zura Bio to Participate in Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2513723390","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513723390?lang=en_us&edition=full_marsco","pubTime":"2025-02-24 20:20","pubTimestamp":1740399645,"startTime":"0","endTime":"0","summary":"Zura Bio ( ($ZURA) ) has issued an update. On February 24, 2025, Zura Bio announced its participation in the Leerink Partners Global Healthcare Con...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/zura-bio-to-participate-in-global-healthcare-conference?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/zura-bio-to-participate-in-global-healthcare-conference?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ZURA","BK4139","HCSG","BK4137"],"gpt_icon":0},{"id":"2513742036","title":"Zura Bio to Present at the Leerink Partners Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2513742036","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513742036?lang=en_us&edition=full_marsco","pubTime":"2025-02-24 19:30","pubTimestamp":1740396600,"startTime":"0","endTime":"0","summary":"HENDERSON, Nev., February 24, 2025----Zura Bio Limited  , a clinical stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases, today announced that members of its senior leadership team will participate in a fireside chat at the Leerink Partners Global Healthcare Conference on Tuesday, March 11, 2025, at 1:40 p.m. ET, and will host investor meetings in Miami, FL.A live webcast and a replay of the presentation will be available on the News & Events page in the Investors & Media section of the Zura Bio website. The presentation will be archived on the website for at least 30 days following the event.Zura Bio is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. Currently, Zura Bio is developing three assets which have completed Phase 1/1b studies. The company is developing a portfolio of therapeutic indications for tibulizumab , crebankitug , and","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zura-bio-present-leerink-partners-113000541.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ZURA","ZURAW","BK4139","HCSG","BK4137"],"gpt_icon":0},{"id":"2505474406","title":"We Think Zura Bio (NASDAQ:ZURA) Can Afford To Drive Business Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2505474406","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505474406?lang=en_us&edition=full_marsco","pubTime":"2025-01-22 20:44","pubTimestamp":1737549848,"startTime":"0","endTime":"0","summary":"Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, although Amazon.com made losses for many years after listing, if you had bought and held the shares since 1999, you would have made a fortune. Having said that, unprofitable companies are risky because they could potentially burn through all their cash and become distressed.Given this risk, we thought we'd take a look at whether Zura Bio  shareholders should be worried about its cash burn. In this report, we will consider the company's annual negative free cash flow, henceforth referring to it as the 'cash burn'. Let's start with an examination of the business' cash, relative to its cash burn.Does Zura Bio Have A Long Cash Runway?So, Should We Worry About Zura Bio's Cash Burn?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/think-zura-bio-nasdaq-zura-124408216.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TSYW.SI","USJW.SI","USAW.SI","BK4112","IE00B64PRP62.GBP","NQmain","ZURAW","LU2095319765.USD",".IXIC","TQQQ","IE00BKPKM429.USD","QLD","IE00B3QW5Z07.USD","LU2210149790.SGD","NVIW.SI","BK4585","IE00BGHQF748.EUR","SQQQ","ZURA","LU2210150020.SGD","QID","BK4139","MNQmain","BK4588","NDAQ","PSQ"],"gpt_icon":1},{"id":"2494392943","title":"Reversal Of Fortune For Zura Bio Insiders Who Made A US$1.01m Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2494392943","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494392943?lang=en_us&edition=full_marsco","pubTime":"2024-12-27 19:53","pubTimestamp":1735300432,"startTime":"0","endTime":"0","summary":"Some of the losses seen by insiders who purchased US$1.01m worth of Zura Bio Limited ( NASDAQ:ZURA ) shares over the...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-zura/zura-bio/news/reversal-of-fortune-for-zura-bio-insiders-who-made-a-us101m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"2494849044","title":"Analysts Offer Insights on Healthcare Companies: 60 Degrees Pharmaceuticals, Inc. (SXTP), Ionis Pharmaceuticals (IONS) and Zura Bio (ZURA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2494849044","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494849044?lang=en_us&edition=full_marsco","pubTime":"2024-12-25 19:51","pubTimestamp":1735127481,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on 60 Degrees Pharmaceuticals, Inc. (SXTP – Research Report), Ionis ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-60-degrees-pharmaceuticals-inc-sxtp-ionis-pharmaceuticals-ions-and-zura-bio-zura?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-60-degrees-pharmaceuticals-inc-sxtp-ionis-pharmaceuticals-ions-and-zura-bio-zura?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ZURA","BK4137","SXTP","HCSG","BK4139","BK4007","IONS"],"gpt_icon":0},{"id":"2493021797","title":"Zura Bio Price Target Maintained With a $5.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2493021797","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493021797?lang=en_us&edition=full_marsco","pubTime":"2024-12-24 19:23","pubTimestamp":1735039380,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ZURA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 24, 2024 06:23 ET (11:23 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZURA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zurabio.com","stockEarnings":[{"period":"1week","weight":0.1748},{"period":"1month","weight":-0.0163},{"period":"3month","weight":-0.4398},{"period":"6month","weight":-0.702},{"period":"1year","weight":-0.5784},{"period":"ytd","weight":-0.516}],"compareEarnings":[{"period":"1week","weight":0.0567},{"period":"1month","weight":-0.0446},{"period":"3month","weight":-0.0802},{"period":"6month","weight":-0.0787},{"period":"1year","weight":0.0308},{"period":"ytd","weight":-0.089}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops Tibulizumab, an IgG-scFv bispecific dual-antagonist antibody engineered by the fusion of ixekizumab and tabalumab that neutralizes IL-17A and BAFF, which is in Phase 2 clinical trial development; ZB-168, a monoclonal antibody that binds and neutralizes the IL-7 receptor chain that impact on diseases driven by IL7 and thymic stromal lymphopoietin immune pathways; and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development. The company is based in Henderson, Nevada.","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.158249},{"month":2,"riseRate":0.75,"avgChangeRate":0.007816},{"month":3,"riseRate":0.5,"avgChangeRate":0.020185},{"month":4,"riseRate":0.5,"avgChangeRate":0.015236},{"month":5,"riseRate":0.333333,"avgChangeRate":0.017561},{"month":6,"riseRate":0.666667,"avgChangeRate":0.041535},{"month":7,"riseRate":0.666667,"avgChangeRate":-0.010132},{"month":8,"riseRate":0.666667,"avgChangeRate":0.016862},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.018218},{"month":10,"riseRate":0.75,"avgChangeRate":-0.049536},{"month":11,"riseRate":0.75,"avgChangeRate":-0.066486},{"month":12,"riseRate":0.25,"avgChangeRate":-0.053882}],"exchange":"NASDAQ","name":"Zura Bio","nameEN":"Zura Bio"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.4","shortVersion":"4.32.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Zura Bio(ZURA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Zura Bio(ZURA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Zura Bio,ZURA,Zura Bio股票,Zura Bio股票老虎,Zura Bio股票老虎国际,Zura Bio行情,Zura Bio股票行情,Zura Bio股价,Zura Bio股市,Zura Bio股票价格,Zura Bio股票交易,Zura Bio股票购买,Zura Bio股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Zura Bio(ZURA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Zura Bio(ZURA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}